Ligand Pharmaceuticals Incorporated (LGND) Ownership
LGND ownership summary
as of October 18, 2026- Institutions
- 116.0% of shares outstanding
- Insiders
- 2.32% of shares outstanding
- Shares outstanding
- 19.9M
- Float
- 19.5M shares available to trade
- Short interest
- 16.11% 2.7M shares short
- Days to cover
- 10.56 short interest up 1.7% vs prior month
- Institutions 115.95%
- Insiders 2.32%
LGND top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 15.56% | 3.1M | $916.5M | +139,073 (+4.7%) | June 30, 2026 |
| 2 | Amvescap Plc. | 6.03% | 1.2M | $355.1M | +378,040 (+45.9%) | June 30, 2026 |
| 3 | Vanguard Portfolio Management, LLC | 5.71% | 1.1M | $336.4M | +38,049 (+3.5%) | June 30, 2026 |
| 4 | Jupiter Topco LLC | 5.22% | 1.0M | $307.5M | +1.0M (0.0%) | June 30, 2026 |
| 5 | HHG PLC | 5.07% | 1.0M | $298.5M | +14,491 (+1.5%) | March 31, 2026 |
| 6 | Vanguard Capital Management, LLC | 4.37% | 871K | $257.4M | +22,861 (+2.7%) | June 30, 2026 |
| 7 | State Street Corp | 4.15% | 827K | $244.3M | +47,683 (+6.1%) | June 30, 2026 |
| 8 | FMR Inc | 3.83% | 763K | $225.4M | +166,700 (+28.0%) | June 30, 2026 |
| 9 | Franklin Templeton Inc | 3.77% | 752K | $222.3M | +178,867 (+31.2%) | June 30, 2026 |
| 10 | Congress Asset Management Company, LLP | 3.31% | 660K | $195.0M | +155,274 (+30.8%) | June 30, 2026 |
| 11 | Geode Capital Management, LLC | 2.95% | 589K | $174.1M | +30,086 (+5.4%) | June 30, 2026 |
| 12 | Delaware Management Holdings Inc | 2.85% | 568K | $168.0M | −4,941 (−0.9%) | June 30, 2026 |
| 13 | Chicago Capital LLC | 2.78% | 553K | $163.6M | −8,240 (−1.5%) | June 30, 2026 |
| 14 | Stephens Inv Mgmt Group LLC | 2.39% | 476K | $140.6M | −19,061 (−3.9%) | June 30, 2026 |
| 15 | Dimensional Fund Advisors, Inc. | 2.15% | 429K | $126.9M | +4,084 (+1.0%) | June 30, 2026 |
| 16 | Massachusetts Financial Services Company | 1.88% | 376K | $111.1M | −35,781 (−8.7%) | June 30, 2026 |
| 17 | The Goldman Sachs Group Inc | 1.62% | 323K | $95.5M | −57,866 (−15.2%) | June 30, 2026 |
| 18 | Loomis, Sayles & Company LP | 1.46% | 292K | $86.2M | −61,404 (−17.4%) | June 30, 2026 |
| 19 | Rice Hall James & Associates, LLC | 1.35% | 270K | $79.8M | −13,515 (−4.8%) | June 30, 2026 |
| 20 | Ranger Investment Management LP | 1.29% | 258K | $76.1M | −10,347 (−3.9%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 2.2M shares and 8 cut 211K.
LGND top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Core S&P Small-Cap ETF | 5.96% | 1.2M | $351.0M | +252 (+0.0%) | September 30, 2026 |
| 2 | Fidelity Contrafund | 5.28% | 1.1M | $311.0M | +1.1M (0.0%) | August 31, 2026 |
| 3 | Invesco Discovery A | 3.18% | 634K | $187.3M | +52,314 (+9.0%) | August 31, 2026 |
| 4 | Vanguard MStar Total Stk Mkt Idx Invest | 3.05% | 607K | $179.4M | −816 (−0.1%) | August 31, 2026 |
| 5 | Franklin DynaTech Fund A | 2.90% | 579K | $171.1M | +28,926 (+5.3%) | August 31, 2026 |
| 6 | iShares Russell 2000 ETF | 2.60% | 518K | $153.2M | −5,952 (−1.1%) | September 30, 2026 |
| 7 | Vanguard Small Cap Index | 2.14% | 426K | $125.9M | −12,027 (−2.7%) | September 30, 2026 |
| 8 | Janus Henderson Triton D | 2.10% | 419K | $123.8M | −46,147 (−9.9%) | August 31, 2026 |
| 9 | Nomura Small Cap Core I | 1.69% | 338K | $99.8M | −47,605 (−12.4%) | August 31, 2026 |
| 10 | Fidelity Small Cap Value Fund | 1.63% | 326K | $96.2M | −45,800 (−12.3%) | July 31, 2026 |
| 11 | Congress Small Cap Growth Institutional | 1.32% | 263K | $77.7M | −6,431 (−2.4%) | September 30, 2026 |
| 12 | Janus Henderson Venture D | 1.29% | 258K | $76.2M | −6,561 (−2.5%) | August 31, 2026 |
| 13 | Vanguard Explorer Inv | 1.26% | 251K | $74.1M | −16,220 (−6.1%) | June 30, 2026 |
| 14 | Fidelity Small Cap Index | 1.10% | 220K | $64.9M | +1,857 (+0.9%) | July 31, 2026 |
| 15 | Fidelity Contrafund K6 | 1.10% | 219K | $64.8M | +219,195 (0.0%) | August 31, 2026 |
| 16 | Neuberger Genesis Inv | 1.02% | 204K | $60.2M | +57,003 (+38.8%) | September 30, 2026 |
| 17 | iShares Russell 2000 Growth ETF | 0.94% | 188K | $55.5M | −238 (−0.1%) | September 30, 2026 |
| 18 | Invesco S&P SmallCap Momentum ETF | 0.93% | 185K | $54.7M | — | September 30, 2026 |
| 19 | iShares S&P Small-Cap 600 Growth ETF | 0.93% | 185K | $54.5M | — | September 30, 2026 |
| 20 | State Street SPDR Port S&P 600 Sm CpETF | 0.91% | 181K | $53.6M | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
LGND insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | John W Kozarich | Sell | $202.23 | 467 | $94,441 |
| 2026-04-01 | Andrew Reardon | Sell | $201.24 | 5,000 | $1.0M |
| 2026-03-23 | Stephen L Sabba | Sell | $207.87 | 1,000 | $207,870 |
| 2026-03-11 | Octavio Espinoza | Sell | $225.00 | 3,057 | $687,825 |
| 2026-03-04 | Andrew Reardon | Sell | $206.35 | 5,000 | $1.0M |
| 2026-03-04 | Octavio Espinoza | Sell | $205.83 | 13,423 | $2.8M |
| 2026-03-03 | Stephen L Sabba | Sell | $201.50 | 2,034 | $409,851 |
| 2026-03-03 | Gilbert Ray Cisneros, Jr. | Buy | $204.24 | — | — |
| 2026-03-02 | John W Kozarich | Sell | $200.50 | 467 | $93,634 |
| 2026-02-02 | John W Kozarich | Sell | $195.91 | 467 | $91,490 |
| 2026-01-15 | Gilbert Ray Cisneros, Jr. | Buy | $196.08 | — | — |
| 2026-01-05 | Gilbert Ray Cisneros, Jr. | Buy | $192.03 | — | — |
| 2026-01-02 | John W Kozarich | Sell | $189.58 | 467 | $88,534 |
| 2025-12-12 | Octavio Espinoza | Sell | $188.31 | 1,804 | $339,711 |
| 2025-12-01 | John W Kozarich | Sell | $195.84 | 467 | $91,457 |
| 2025-11-03 | John W Kozarich | Sell | $191.05 | 467 | $89,220 |
| 2025-10-01 | John W Kozarich | Sell | $179.44 | 467 | $83,798 |
| 2025-09-23 | Jason Aryeh | Sell | $170.81 | 10,000 | $1.7M |
| 2025-09-02 | John W Kozarich | Sell | $162.26 | 467 | $75,775 |
| 2025-08-01 | John W Kozarich | Sell | $131.88 | 467 | $61,588 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
LGND shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns LGND
Institutional investors own 116.0% of Ligand Pharmaceuticals's shares and insiders 2.32%. The largest holder is BlackRock Inc with 15.56% of the shares (3.1M), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 8 reduced their stake in the latest filings. Short interest is 16.11% of the float, or 10.56 days of average trading volume. The share count rose 1.7% since 2014.
Related: LGND analyst forecast, LGND key metrics. See the LGND stock overview for the latest quote and news.
LGND ownership FAQ
Who owns the most Ligand Pharmaceuticals stock?
The largest shareholders of Ligand Pharmaceuticals are BlackRock Inc (15.56%), Amvescap Plc. (6.03%), Vanguard Portfolio Management, LLC (5.71%), Jupiter Topco LLC (5.22%), HHG PLC (5.07%).
What percentage of Ligand Pharmaceuticals is owned by institutions?
Institutions hold 116.0% of Ligand Pharmaceuticals's shares outstanding; insiders hold 2.32%.
Which funds own Ligand Pharmaceuticals?
The largest fund holders of Ligand Pharmaceuticals are iShares Core S&P Small-Cap ETF (5.96%), Fidelity Contrafund (5.28%), Invesco Discovery A (3.18%), Vanguard MStar Total Stk Mkt Idx Invest (3.05%), Franklin DynaTech Fund A (2.90%).
What is Ligand Pharmaceuticals's short interest?
2.7M shares of Ligand Pharmaceuticals were sold short, 16.11% of the float; at the average daily volume it would take 10.56 days to cover.
Are insiders buying or selling Ligand Pharmaceuticals?
Of the latest 20 reported insider transactions in Ligand Pharmaceuticals (since August 1, 2025), 3 were purchases and 17 were sales.
How many shares of Ligand Pharmaceuticals are outstanding?
Ligand Pharmaceuticals has 19.9M shares outstanding, of which 19.5M are in the public float.